A Norwegian Observational Trial Evaluating the Treatment of Advanced Renal Cell Cancer Patients Under Treatment of Afinitor

NCT01390519 · clinicaltrials.gov ↗

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Renal Cell Carcinoma (mRCC)

Interventions

OTHER: everolimis

Sponsor

Novartis Pharmaceuticals